Dr Atmosukarto is the Managing Director and Chief Scientific Officer of Lipotek Pty Ltd.  Lipotek, a niche biotech company operating from the John Curtin School of Medical Research at the ANU. The company specialises on the use of its liposome platform for the development of vaccines.  More recently it has used its liposomes as delivery-vehicles for immunomodulators and small molecule drug products.  The company has also adapted its multivalent anchoring liposomes for applications in flowcytometry and in vivo bioimaging techniques which can be used in the screening of target specific ligands. The company continues to explore innovative uses for its liposome platform.